SAVIENT PHARMACEUTICALS INC: cashflow_financing
| Value | {"amount": 223364000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-09-30 |
| Status | current |
| Entity | SAVIENT PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f234b0cb-ea7f-45b9-82e0-a96aafae32bf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-460442 · Open the official SEC filing →Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000722104/cashflow-financing/2011-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f234b0cb-ea7f-45b9-82e0-a96aafae32bf
History
- supersedes {"amount": 223330000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001193125-11-302386)